Abstract:Background The gut microbiome and microbiome-gut-brain (MGB) axis have been receiving increasing attention for their role in the regulation of mental behavior and possible biological basis of psychiatric disorders. With the advance of next-generation sequencing technology, characterization of the gut microbiota in schizophrenia (SZ) patients can provide rich clues for the diagnosis and prevention of SZ. Methods In this study, we compared the differences in the fecal microbiota between 82 SZ patients and 80 demographically matched normal controls (NCs) by 16S rRNA sequencing and analyzed the correlations between altered gut microbiota and symptom severity. Results The alpha diversity showed no significant differences between the NC and SZ groups, but the beta diversity revealed significant community-level separation in microbiome composition between the two groups (pseudo- F =3.337, p < 0.001, uncorrected). At the phylum level, relatively more Actinobacteria and less Firmicutes ( p < 0.05, FDR corrected) were found in the SZ group. At the genus level, the relative abundances of Collinsella , Lactobacillus , Succinivibrio , Mogibacterium , Corynebacterium , undefined Ruminococcus and undefined Eubacterium were significantly increased, whereas the abundances of Adlercreutzia , Anaerostipes , Ruminococcus and Faecalibacterium were decreased in the SZ group compared to the NC group ( p < 0.05, FDR corrected). We performed PICRUSt analysis and found that several metabolic pathways differed significantly between the two groups, including the Polyketide sugar unit biosynthesis, Valine, Leucine and Isoleucine biosynthesis, Pantothenate and CoA biosynthesis, C5-Branched dibasic acid metabolism, Phenylpropanoid biosynthesis, Ascorbate and aldarate metabolism, Nucleotide metabolism and Propanoate metabolism pathways ( p < 0.05, FDR corrected). Among the SZ group, the abundance of Succinivibrio was positively correlated with the total Positive and Negative Syndrome Scale (PANSS) scores ( r = 0.24, p < 0.05, uncorrected) as well as the general PANSS scores ( r = 0.22, p < 0.05, uncorrected); Corynebacterium was negatively related to the negative scores of PANSS ( r = 0.22, p < 0.05, uncorrected). Conclusions Our findings provided evidence of altered gut microbial composition in SZ group. In addition, we found that Succinvibrio and Corynebacterium were associated with the severity of symptoms for the first time, which may provide some new biomarkers for the diagnosis of SZ.

Association Between Fecal Microbiota and Generalized Anxiety Disorder: Severity and Early Treatment Response.

Altered gut microbiota profile in patients with generalized anxiety disorder.

Gut microbiota and inflammatory factor characteristics in major depressive disorder patients with anorexia

Alteration of the Gut Microbiome in First-Episode Drug-Naïve and Chronic Medicated Schizophrenia Correlate with Regional Brain Volumes.

White Matter Integrity Alterations in First Episode, Treatment-Naive Generalized Anxiety Disorder

Taxonomic and Metabolic Signatures of Gut Microbiota for Assessing the Severity of Depression and Anxiety in Major Depressive Disorder Patients.

Fecal microbiota transplant on Escherichia-Shigella gut composition and its potential role in the treatment of generalized anxiety disorder: A systematic review

Association between generalized anxiety disorder and live microbes intake in the United States general population

Fecal Microbiota in Pediatric Depression and Its Relation to Bowel Habits.

Regulation of miRNA expression in the prefrontal cortex by fecal microbiota transplantation in anxiety-like mice

Gut microbiome diversity mediates the association between right dorsolateral prefrontal cortex and anxiety level

Association between gut microbiota and anxiety disorders: a bidirectional two-sample mendelian randomization study

Altered fecal microbiota composition in patients with major depressive disorder

Features of gut microbiota and short-chain fatty acids in patients with first-episode depression and their relationship with the clinical symptoms

Altered gut microbiota associated with symptom severity in schizophrenia

Improving precision management of anxiety disorders: a Mendelian randomization study targeting specific gut microbiota and associated metabolites

Altered Metabolism of the Microbiota-Gut-Brain Axis Is Linked With Comorbid Anxiety in Fecal Recipient Mice of Myasthenia Gravis

Association analysis of gut microbiota and efficacy of SSRIs antidepressants in patients with major depressive disorder

Relationships between the gut microbiome and brain functional alterations in first-episode, drug-naïve patients with major depressive disorder

Changes of Gut Microbiota Reflect the Severity of Major Depressive Disorder: a Cross Sectional Study

The Variation Characteristics of Fecal Microbiota in Remission UC Patients with Anxiety and Depression